Search

everythinglearnresearchcommunity

for

Search:↓

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Immune cells affect hair growth and could lead to new hair loss treatments.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

A lotion with 5% minoxidil boosts the immune response in guinea pigs.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.